EVO ICL vs SMILE in 2026: The Premium High-Myopia Decision
For high-myopia patients considering a premium refractive option, EVO ICL and SMILE are the two credible choices. One reshapes the cornea; the other adds a lens inside the eye. Here’s how they actually compare.
Why this comparison matters
Once a patient’s prescription pushes past -6 or -7 diopters and their corneal thickness is anything less than ideal, the conversation moves beyond standard LASIK. The two premium options that come up: EVO ICL (an implantable lens) and SMILE (a minimally-invasive corneal procedure). Both can serve high-myopia patients that standard LASIK cannot. But they solve the problem in completely different ways, with different price points, different reversibility profiles, and different long-term risk structures.
Choosing between them isn’t about which is “better” — both are excellent for their target patients. It’s about which fits your specific corneal anatomy, prescription, and personal preferences.
What each procedure actually is
SMILE uses a femtosecond laser to create a lenticule of tissue inside the cornea and extracts it through a small incision. The cornea is permanently reshaped by removing tissue. Recovery is fast (2–3 days to functional vision), the procedure is comfortable, and it preserves more corneal biomechanics than LASIK.
EVO ICL implants a soft biocompatible lens in front of the natural lens, behind the iris. The cornea is unchanged; the correction happens entirely through the added lens. The procedure is intraocular (inside the eye), which is more invasive than a corneal procedure but leaves the corneal architecture completely intact. It’s also reversible — the lens can be removed later if needed.
Who each is best for
SMILE is best for: myopic patients from -1 to -10 D with adequate corneal thickness (typically 500+ microns), astigmatism up to -5 D, and normal corneal topography. Best value for high-myopia patients whose corneas can still handle a lenticule extraction.
EVO ICL is best for: myopic patients beyond -10 D (SMILE’s upper limit in most jurisdictions), patients with corneal thickness below SMILE’s minimum for their prescription, patients with irregular corneal topography that disqualifies SMILE, patients with severe baseline dry eye who want maximum corneal preservation, and patients who want the reversibility that only ICL offers.
Recovery reality
SMILE recovery is faster: functional vision by day 2–3, back at work by day 3–4, full stabilization at 4–6 weeks. The small incision heals with minimal discomfort. Most patients describe SMILE recovery as easier than LASIK.
EVO ICL recovery is also fast but different in character: functional vision typically by day 1–2, though visual clarity can fluctuate for the first week as the eye adjusts to the implant. Post-op steroid and antibiotic drops are used for 2–4 weeks. Because the procedure is intraocular rather than corneal, there’s no dry-eye recovery period and no corneal healing timeline — the tear film and cornea are unaffected. Some patients report brief pressure or halos in the first week that resolve.
Cost across destinations
EVO ICL costs significantly more than SMILE at every destination — typically 2 to 2.5 times the price. Colombia’s EVO ICL runs $3,800–$4,800 vs SMILE at $1,600–$2,000. Turkey’s runs $4,200–$5,200 vs SMILE at $2,000–$2,800. The premium reflects the physical lens (a significant equipment input), intraocular surgical complexity, and specialized surgeon skill.
Both procedures are dramatically cheaper internationally than in the US, where EVO ICL typically runs $10,000–$14,000 for both eyes and SMILE runs $4,500–$6,500. The cost math for international travel is compelling for either procedure at premium destinations.
Risks and honest downsides of each
SMILE’s downsides for high-myopia specifically: at prescriptions approaching -10 D, the lenticule required is larger and the residual corneal bed is thinner — approaching the safe minimum. Enhancement pathways are more complex than for LASIK (usually surface PRK). Fewer surgeons globally have high SMILE case volumes at the high-myopia end.
EVO ICL’s downsides: cataract acceleration risk (uncommon but real, related to sizing and positioning), elevated intraocular pressure requiring monitoring, endothelial cell loss over time (typically small but tracked), and the intrinsic risks of intraocular surgery (rare but real: endophthalmitis, dislocation, need for exchange). Requires lifelong monitoring — regular follow-ups with an eye doctor to confirm the lens is positioned correctly and the eye is stable.
Where they overlap and where they diverge
The overlap zone: high-myopia patients (-6 to -10 D) with adequate corneal thickness and normal topography. Both procedures deliver excellent outcomes for this profile, and the choice comes down to cost tolerance, dry-eye baseline, and reversibility preference.
The divergence: beyond -10 D or in thin corneas, EVO ICL is the appropriate procedure and SMILE isn’t a candidate. Below -6 D with normal corneas, SMILE is more efficient and standard LASIK often works too — EVO ICL is overkill. In the overlap zone, either works, and personal preferences drive the choice.
| Destination | EVO ICL | SMILE |
|---|---|---|
| Colombia | $3,800–$4,800 | $1,600–$2,000 |
| Mexico | $4,500–$5,500 | $2,200–$3,200 |
| Turkey | $4,200–$5,200 | $2,000–$2,800 |
| Thailand | $4,800–$6,000 | $2,400–$3,400 |
| India | $3,200–$4,200 | $1,400–$2,000 |
Hover any bar for the exact midpoint. Individual quotes depend on prescription, corneal parameters, and equipment tier.
Scores reflect published clinical literature, procedure characteristics, and long-term outcome data. Dry eye safety and cornea preservation are inverted (higher = safer for these axes).
The verdict: which one is right for you
Choose SMILE if your prescription is under -10 D, your corneas have adequate thickness for the specific lenticule your prescription requires, and you want the fastest and most cost-effective premium refractive option. SMILE’s outcomes for high-myopia patients with good corneal anatomy are excellent, and the cost is roughly half of EVO ICL.
Choose EVO ICL if your prescription is beyond -10 D, your corneas are too thin for safe SMILE, you have severe baseline dry eye, you value reversibility, or you have irregular corneal topography. For these patients, EVO ICL isn’t an upgrade — it’s the appropriate procedure. Accept the higher cost and the lifelong monitoring requirement for the specific capabilities EVO ICL provides.
Don’t let a clinic push EVO ICL as a “premium upgrade” if SMILE is clinically appropriate for your case. And don’t let cost pressure push you toward SMILE if your anatomy indicates EVO ICL. Get a thorough consultation with a surgeon who performs both at meaningful volume.
Frequently asked questions
Can EVO ICL correct any prescription SMILE can’t?
Essentially yes. EVO ICL treats myopia up to about -20 D. SMILE tops out around -10 D in most jurisdictions. For patients between -10 and -20 D, EVO ICL is the primary option. Above -20 D, phakic IOL specialists explore custom or unusual options.
Is EVO ICL really reversible in practice?
Yes. Removal is a reverse of the implantation procedure — the same small corneal incision is used to fold and extract the lens. Some patients later have their ICL exchanged for a different power if their prescription drifts. In practice, most EVO ICL patients keep the lens permanently, but the reversibility option is meaningful for patients who value it.
Which has better long-term outcome data?
SMILE has 10+ years of substantial outcome data, showing excellent long-term stability. EVO ICL (specifically the current EVO design with the CentraFLOW port) has ~10 years of data, with the underlying ICL platform having 20+ years of history in earlier versions. Both are well-supported. Long-term concerns for EVO ICL center on endothelial cell density and cataract acceleration; both are monitored via regular follow-ups.
Can I have EVO ICL if I’ve already had SMILE or LASIK?
Yes. EVO ICL is compatible with prior corneal refractive surgery because it operates inside the eye, not on the cornea. This is a legitimate enhancement pathway for patients whose prescription drifts after SMILE or LASIK and who don’t want additional corneal work. However, the biometry and sizing calculations are more complex after prior corneal surgery, so choose a surgeon experienced with post-refractive EVO ICL.
What’s the total cost of a Colombia EVO ICL vs SMILE trip?
Colombia SMILE total-trip cost (surgery + flight + 5 nights hotel + coordination) typically runs $2,800–$3,800. Colombia EVO ICL total-trip cost typically runs $5,000–$6,500. That’s roughly $2,000–$2,700 more for EVO ICL. In the US context, EVO ICL runs $10,000–$14,000 for both eyes, so even the higher international EVO ICL cost is meaningful savings versus staying home.
Tell me your prescription, corneal thickness (if you have it), and lifestyle. I’ll give you an honest read on which of these two procedures your eyes are actually a candidate for — and whether either is the right call.
Message on WhatsApp →